DKK350.95
4.45% yesterday
Copenhagen, Aug 26, 04:59 pm CET
ISIN
DK0062498333
Symbol
NOVO B

Novo Nordisk Target price 2025 - Analyst rating & recommendation

Novo Nordisk Classifications & Recommendation:

Buy
55%
Hold
39%
Sell
6%

Novo Nordisk Price Target

Target Price DKK510.00
Price DKK350.95
Potential
Number of Estimates 27
27 Analysts have issued a price target Novo Nordisk 2026 . The average Novo Nordisk target price is DKK510.00. This is higher than the current stock price. The highest price target is
DKK945.00 169.27%
register free of charge
, the lowest is .
A rating was issued by 31 analysts: 17 Analysts recommend Novo Nordisk to buy, 12 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Novo Nordisk stock has an average upside potential 2026 of . Most analysts recommend the Novo Nordisk stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion DKK 290.40 319.48
25.03% 10.01%
EBITDA Margin 48.98% 53.18%
6.29% 8.57%
Net Margin 34.78% 35.05%
3.48% 0.79%

26 Analysts have issued a sales forecast Novo Nordisk 2025 . The average Novo Nordisk sales estimate is

DKK319b
Unlock
. This is
2.42% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
DKK348b 11.47%
Unlock
, the lowest is
DKK304b 2.66%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 DKK290b 25.03%
2025
DKK319b 10.01%
Unlock
2026
DKK351b 9.93%
Unlock
2027
DKK384b 9.32%
Unlock
2028
DKK424b 10.33%
Unlock
2029
DKK464b 9.49%
Unlock
2030
DKK499b 7.70%
Unlock
2031
DKK474b 5.07%
Unlock
2032
DKK464b 2.04%
Unlock

23 Analysts have issued an Novo Nordisk EBITDA forecast 2025. The average Novo Nordisk EBITDA estimate is

DKK170b
Unlock
. This is
6.98% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
DKK193b 21.44%
Unlock
, the lowest is
DKK150b 5.32%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 DKK142b 32.90%
2025
DKK170b 19.44%
Unlock
2026
DKK201b 18.13%
Unlock
2027
DKK226b 12.70%
Unlock
2028
DKK205b 9.47%
Unlock
2029
DKK220b 7.58%
Unlock
2030
DKK230b 4.57%
Unlock
2031
DKK241b 4.81%
Unlock
2032
DKK228b 5.59%
Unlock

EBITDA Margin

2024 48.98% 6.29%
2025
53.18% 8.57%
Unlock
2026
57.15% 7.47%
Unlock
2027
58.91% 3.08%
Unlock
2028
48.34% 17.94%
Unlock
2029
47.50% 1.74%
Unlock
2030
46.12% 2.91%
Unlock
2031
50.92% 10.41%
Unlock
2032
49.08% 3.61%
Unlock

26 Novo Nordisk Analysts have issued a net profit forecast 2025. The average Novo Nordisk net profit estimate is

DKK112b
Unlock
. This is
0.82% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
DKK124b 11.88%
Unlock
, the lowest is
DKK104b 6.74%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 DKK101b 20.68%
2025
DKK112b 10.88%
Unlock
2026
DKK123b 9.46%
Unlock
2027
DKK136b 10.79%
Unlock
2028
DKK151b 11.24%
Unlock
2029
DKK169b 11.72%
Unlock
2030
DKK186b 10.37%
Unlock
2031
DKK162b 12.92%
Unlock
2032
DKK164b 0.87%
Unlock

Net Margin

2024 34.78% 3.48%
2025
35.05% 0.79%
Unlock
2026
34.90% 0.43%
Unlock
2027
35.37% 1.35%
Unlock
2028
35.66% 0.82%
Unlock
2029
36.39% 2.05%
Unlock
2030
37.29% 2.47%
Unlock
2031
34.21% 8.26%
Unlock
2032
35.23% 2.98%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share DKK 22.63 25.23
21.54% 11.49%
P/E 14.56
EV/Sales 5.31

26 Analysts have issued a Novo Nordisk forecast for earnings per share. The average Novo Nordisk EPS is

DKK25.23
Unlock
. This is
1.04% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
DKK27.99 12.09%
Unlock
, the lowest is
DKK23.33 6.57%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 DKK22.63 21.54%
2025
DKK25.23 11.49%
Unlock
2026
DKK27.61 9.43%
Unlock
2027
DKK30.59 10.79%
Unlock
2028
DKK34.03 11.25%
Unlock
2029
DKK38.02 11.72%
Unlock
2030
DKK41.96 10.36%
Unlock
2031
DKK36.54 12.92%
Unlock
2032
DKK36.86 0.88%
Unlock

P/E ratio

Current 14.71 67.53%
2025
14.56 1.02%
Unlock
2026
13.30 8.65%
Unlock
2027
12.01 9.70%
Unlock
2028
10.79 10.16%
Unlock
2029
9.66 10.47%
Unlock
2030
8.75 9.42%
Unlock
2031
10.05 14.86%
Unlock
2032
9.96 0.90%
Unlock

Based on analysts' sales estimates for 2025, the Novo Nordisk stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.44 54.52%
2025
5.31 2.43%
Unlock
2026
4.83 9.03%
Unlock
2027
4.42 8.53%
Unlock
2028
4.00 9.36%
Unlock
2029
3.66 8.67%
Unlock
2030
3.39 7.15%
Unlock
2031
3.58 5.34%
Unlock
2032
3.65 2.09%
Unlock

P/S ratio

Current 5.18 56.79%
2025
5.06 2.36%
Unlock
2026
4.60 9.03%
Unlock
2027
4.21 8.53%
Unlock
2028
3.81 9.36%
Unlock
2029
3.48 8.67%
Unlock
2030
3.23 7.15%
Unlock
2031
3.41 5.34%
Unlock
2032
3.48 2.09%
Unlock

Current Novo Nordisk Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BERENBERG
Locked
Locked
Locked Jul 14 2025
ROTHSCHILD & CO REDBURN
Locked
Locked
Locked Jul 14 2025
TD COWEN
Locked
Locked
Locked Jul 13 2025
GUGGENHEIM SECURITIES LLC
Locked
Locked
Locked Jul 10 2025
ODDO BHF
Locked
Locked
Locked Jun 22 2025
CRISPIDEA PRIVATE LIMITED
Locked
Locked
Locked May 26 2025
HSBC
Locked
Locked
Locked May 25 2025
Analyst Rating Date
Locked
BERENBERG:
Locked
Locked
Jul 14 2025
Locked
ROTHSCHILD & CO REDBURN:
Locked
Locked
Jul 14 2025
Locked
TD COWEN:
Locked
Locked
Jul 13 2025
Locked
GUGGENHEIM SECURITIES LLC:
Locked
Locked
Jul 10 2025
Locked
ODDO BHF:
Locked
Locked
Jun 22 2025
Locked
CRISPIDEA PRIVATE LIMITED:
Locked
Locked
May 26 2025
Locked
HSBC:
Locked
Locked
May 25 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today